# Development of a Triage Tool for Stratification and Referral of Women at Risk of Preeclampsia in Low‐Resource Antenatal Settings: A Prospective Cohort Study

**Authors:** Bismark Opoku Mensah, Ernestina Obenewaa Anim, Abena Serwaa Adjei

PMC · DOI: 10.1002/hsr2.71916 · Health Science Reports · 2026-02-26

## TL;DR

A new tool was developed to help identify women at high risk of preeclampsia during pregnancy using simple clinical data, which could improve care in low-resource settings.

## Contribution

A novel points-based triage tool for preeclampsia risk stratification using routinely collected antenatal data in low-resource settings.

## Key findings

- The tool incorporates maternal age, nulliparity, blood pressure, family history, and proteinuria to calculate a risk score.
- Women with a score of ≥16 had a 30.2% incidence of preeclampsia, compared to 5.1% in low-risk groups.
- The tool showed good performance with an AUC of 0.83, sensitivity of 78.3%, and specificity of 83.3%.

## Abstract

Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality globally, with high incidence and case fatality rates in low‐ and middle‐income countries (LMICs). Early identification of at‐risk women is critical, yet many predictive models require laboratory or imaging resources that are unavailable in resource‐limited settings. This study aimed to develop a points‐based clinical triage tool for preeclampsia risk stratification using routinely collected antenatal care (ANC) data.

A prospective cohort study of 703 pregnant women attending ANC was conducted, with retrospective extraction of baseline clinical data. Maternal sociodemographic characteristics, obstetric history, blood pressure (BP) measurements, and proteinuria screening results were analysed. Multivariable logistic regression was used to identify independent predictors of preeclampsia, and model performance was evaluated using discrimination, calibration, and internal bootstrapping. A weighted scoring system was derived from regression coefficients, and receiver operating characteristic (ROC) analysis was used to determine optimal cut‐off values for risk stratification.

A five‐component clinical triage tool for risk stratification of preeclampsia was developed. The tool incorporates maternal age (≥ 35 years), nulliparity, elevated blood pressure (≥ 140/90 mmHg), family history of preeclampsia, and dipstick proteinuria (≥ + 1), generating a total risk score ranging from 0 to 18. Based on the risk score, women were categorised into low risk (0–10 points), moderate risk (11–15 points), and high risk (≥ 16 points) groups. The incidence of preeclampsia increased across these categories, from 5.1% in the low‐risk group to 30.2% among women classified as high risk. At the high‐risk threshold (≥ 16 points), the tool demonstrated good discriminatory performance (AUC = 0.83), with a sensitivity of 78.3% and a specificity of 83.3% for identifying women who subsequently developed preeclampsia.

This study demonstrates that a simple, points‐based clinical triage tool using routinely collected antenatal data has potential for stratifying preeclampsia risk.

## Linked entities

- **Diseases:** preeclampsia (MONDO:0005081)

## Full-text entities

- **Genes:** DBP (D-box binding PAR bZIP transcription factor) [NCBI Gene 1628] {aka DABP, taxREB302}
- **Diseases:** dysfunction (MESH:D006331), Hypertension (MESH:D006973), elevated blood (MESH:D006402), Pressure (MESH:D003668), GH (MESH:D046110), weight gain (MESH:D015430), Obesity (MESH:D009765), preeclamptic (MESH:C538543), Proteinuria (MESH:D011507), PE (MESH:D011225), chronic renal disease (MESH:D051436), diabetes mellitus (MESH:D003920)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946488/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946488/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946488/full.md

---
Source: https://tomesphere.com/paper/PMC12946488